These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8464349)

  • 1. The effect of culture medium composition on ether lipid cytotoxic activity.
    Diomede L; Piovani B; Modest EJ; Salmona M
    Lipids; 1993 Mar; 28(3):189-92. PubMed ID: 8464349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action.
    Diomede L; Colotta F; Piovani B; Re F; Modest EJ; Salmona M
    Int J Cancer; 1993 Jan; 53(1):124-30. PubMed ID: 8416196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ether lipid cytotoxicity by reducing membrane cholesterol content.
    Diomede L; Piovani B; Modest EJ; Noseda A; Salmona M
    Int J Cancer; 1991 Sep; 49(3):409-13. PubMed ID: 1917140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C is not involved in cholesterol-induced resistance to synthetic ether lipids.
    Diomede L; Salmona M; Lamorte G; Piovani B; Sozzani S
    Anticancer Res; 1993; 13(5A):1331-4. PubMed ID: 8239503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
    Wagner BA; Buettner GR; Burns CP
    Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3.
    Heesbeen EC; Rijksen G; van Heugten HG; Verdonck LF
    Leuk Res; 1995 Jun; 19(6):417-25. PubMed ID: 7596155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Small GW; Strum JC; Daniel LW
    Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antineoplastic ether lipids on model and biological membranes.
    Noseda A; Godwin PL; Modest EJ
    Biochim Biophys Acta; 1988 Nov; 945(1):92-100. PubMed ID: 3179313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells.
    Diomede L; Piovani B; Re F; Principe P; Colotta F; Modest EJ; Salmona M
    Int J Cancer; 1994 Jun; 57(5):645-9. PubMed ID: 8194871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
    Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
    Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES; Kelley EE; Modest EJ; Burns CP
    Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
    Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
    Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of ATPase activity by cholesterol and synthetic ether lipids in leukemic cells.
    Diomede L; Bianchi R; Modest EJ; Piovani B; Bubba F; Salmona M
    Biochem Pharmacol; 1992 Feb; 43(4):803-7. PubMed ID: 1311590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
    Principe P; Sidoti C; Braquet P
    Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
    Trulla LL; Magistrelli A; Salmona M; Tacconi MT
    Lipids; 1993 May; 28(5):403-6. PubMed ID: 8316047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition.
    Diomede L; Damia G; D'Incalci M; Imperatori L; Algeri M; Modest EJ; Salmona M
    Int J Cancer; 1994 Nov; 59(4):580-1. PubMed ID: 7960229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.